Back to Authors

Bayan, Semirra

0000-0003-3511-1969

Mayo Clinic

Mayo Clinic, Department of Otorhinolaryngology, Rochester, Minnesota, USA.

Citations 23

Comments on “Cardiothoracic Patients with Unilateral Vocal Fold Paralysis: Pneumonia Rates Following Injection Laryngoplasty” by Tsai et al
Barnes, Jason H. , Orbelo, Diana M. , Armstrong, Michael , Bayan, Semirra L. , Lohse, Christine M. , Ekbom, Dale C. , Armstrong, Michael F, Bayan, Semirra , Orbelo, Diana

Annals of Otology, Rhinology & Laryngology | August 19, 2020 | Volume: 130 | Issue: 2 | Pages: 225-225

10.1177/0003489420949494 Get It

Cardiothoracic Patients with Unilateral Vocal Fold Paralysis: Pneumonia Rates Following Injection Laryngoplasty
Barnes, Jason H. , Orbelo, Diana M. , Armstrong, Michael , Bayan, Semirra L. , Lohse, Christine M. , Ekbom, Dale C. , Armstrong, Michael F, Bayan, Semirra , Orbelo, Diana

Annals of Otology, Rhinology & Laryngology | June 8, 2020 | Volume: 129 | Issue: 11 | Pages: 1129-1134

10.1177/0003489420933650 Get It

Objective: Recurrent laryngeal nerve injury is a potential complication of cardiothoracic surgery and cause of unilateral vocal fold paralysis (UVFP). Injection laryngoplasty (IL) is an intervention offered to patients with UVFP to alleviate symptoms including dysphagia, dysphonia and weak cough. There is no definitive evidence that IL prevents pneumonia. In this study, we compare rates of pneumonia in patients with UVFP secondary to cardiothoracic surgery who did or did not undergo IL. Methods: A retrospective chart review identified patients diagnosed with UVFP by an otolaryngologist using flexible laryngoscopy following cardiothoracic surgery from January 1, 2008 to December 31, 2017. Each subject was grouped by IL status and assessed for subsequent pneumonia within 6 months of their diagnosis of UVFP. The association of IL with pneumonia was evaluated using Cox proportional hazards regression. Results: Of 92 patients who met inclusion criteria, 35 (38%) underwent IL and 57 (62%) did not. Twenty patients developed pneumonia, four who had undergone IL and 16 who had not; 12 patients developed aspiration pneumonia including two having undergone IL and 10 who had not. Those who had IL were less likely to develop total pneumonia compared to those who had not (HR = 0.33, P = .045). The protective effect of IL was not as clearly sustained when measuring for aspiration pneumonia, specifically (HR = 0.34; P = .10). Discussion: Injection laryngoplasty may reduce the risk of pneumonia in patients with UVFP secondary to cardiothoracic surgery; however, further research is needed to quantify the potential protective nature of IL in this patient population. Level of evidence: 3 (A retrospective cohort study).
Acute airway compromise after recombinant human TSH administration: A case report and review of the literature
Dowling, Eric M. , Kasperbauer, Jan L. , Bayan, Semirra L. , Dowling, Eric , Kasperbauer, Jan , Bayan, Semirra, Bayan, Semirra , Morris, John

The Laryngoscope | December 10, 2019 | Volume: 130 | Issue: 11 | Pages: 2725-2727

10.1002/lary.28439 Get It

Radioiodine ablation is a commonly utilized treatment for differentiated thyroid carcinoma. Uptake of radioiodine can be enhanced by pretreatment with thyroid hormone withdrawal or administration of recombinant human thyroid‐stimulating hormone (rhTSH). rhTSH is generally well‐tolerated with minimal adverse effects. However, in patients with extensive tumor burden in confined anatomic spaces, rapid enlargement of normal or neoplastic thyroid tissue secondary to rhTSH administration can result in significant compressive effects. In this report, we describe a case of rapid airway deterioration requiring intubation in a patient with involvement of the thyroid cartilage by papillary thyroid carcinoma.Laryngoscope, 122:0000–0000, 2019 Laryngoscope, 130:2725–2727, 2020